Sagility India IPO
Historical offer record. This offer is closed for applications. Prices and subscriptions describe the past offer; GMP observations are unofficial past records, not current quotes or listing predictions.
Data provider: FinAPI. This is a third-party summary, not an official prospectus. Read our data limitations and editorial policy.
No GMP observations are available for this historical offer record. No premium or listing-gain estimate is shown.
Price band
₹28 – ₹30
Lot size
500 shares
Offer application amount
₹15,000
Issue size
₹2106 Cr
Historical offer amount for 1 lot at the upper issue price. Confirm the lot size and application terms in the issuer prospectus.
Reported IPO schedule
| Open date | 5 Nov 2024 |
| Close date | 7 Nov 2024 |
| Allotment finalisation | 8 Nov 2024 |
| Refund initiation | 8 Nov 2024 |
| Shares credited to demat | 11 Nov 2024 |
| Reported listing date | 12 Nov 2024 |
About Sagility India
Sagility India Limited was formed on July 28, 2021, to provide tailored solutions for various medical sectors, such as hospitals, health systems, physician groups, labs, and DME companies. It has a revenue of 47,535.60 crore which has increased compared to the last two years. This company not only serves domestic clients but also expands its business overseas. They are strengthening their relationships with existing clients while also acquiring new ones and enhancing their technology for the betterment of customers.
Company summary supplied by FinAPI. Read the prospectus for the issuer's disclosures and audited financials.
Offer documents and primary references
Read the issuer's offer document and any corrigenda for the full disclosures. A third-party details page is a summary; SEBI filing access does not imply an endorsement of the offer or this website.
IPO information is sourced from public feeds and shown for general information only. It is not a recommendation to apply for this or any IPO. IPOs are equity investments and carry market risk; listing gains are not guaranteed and SME IPOs are especially volatile. Grey Market Premium (GMP) is unofficial and not endorsed by SEBI or the exchanges. Equity IPOs are applied for through a demat and trading account, not through mutual fund distribution services. Read the RHP and consult a SEBI-registered investment adviser before investing.